ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Adge
|
130 |
37K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
130
|
37K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2024 BrainChip Discussion
|
|
Adge
|
4.8K |
1.8M |
46 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
46
|
|
ASX - By Stock
|
BRN |
Re:
2024 BrainChip Discussion
|
|
Adge
|
4.8K |
1.8M |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Adge
|
24 |
7.5K |
18 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
24
|
7.5K
|
18
|
|
ASX - By Stock
|
ADO |
Re:
2024 - The year of ADO
|
|
Adge
|
727 |
233K |
65 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
727
|
233K
|
65
|
|
ASX - By Stock
|
AVR |
Re:
TCT 2023 PHYSICIAN PANEL INTERVIEW
|
|
Adge
|
21 |
7.2K |
17 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
21
|
7.2K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
2023 BrainChip Discussion
|
|
Adge
|
6.3K |
2.3M |
19 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
6.3K
|
2.3M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Share Purchase Plan Closing Date Extended
|
|
Adge
|
700 |
242K |
24 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
700
|
242K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
Adge
|
60 |
24K |
6 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
24K
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Adge
|
32K |
15M |
9 |
30/08/23 |
30/08/23 |
Charts
|
32K
|
15M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $35M Placement & Launches c.$30M SPP
|
|
Adge
|
454 |
175K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
454
|
175K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Response to Notice received under s249D of Corporations Act
|
|
Adge
|
85 |
19K |
1 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
85
|
19K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exceptional Results in Second Valve-in-Valve Case
|
|
Adge
|
42 |
12K |
4 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Adge
|
137K |
52M |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
137K
|
52M
|
2
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Section 708A Cleansing Notice
|
|
Adge
|
7 |
4.8K |
0 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
7
|
4.8K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
ferroglobe-accuses-asx-company-of-using-confidential-ip-after-failed-collaboration
|
|
Adge
|
702 |
258K |
7 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
702
|
258K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Adge
|
1.0K |
390K |
7 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
390K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Adge
|
1.0K |
390K |
23 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
390K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Adge
|
1.3K |
545K |
2 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
545K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO interview on Proactive Investors
|
|
Adge
|
27 |
7.5K |
2 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
27
|
7.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Adge
|
3.4K |
1.1M |
6 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Adge
|
3.4K |
1.1M |
12 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
12
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Favourable Ruling in ICC Emergency Arbitration Proceedings
|
|
Adge
|
365 |
194K |
49 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
365
|
194K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Voluntary Suspension
|
|
Adge
|
49 |
32K |
3 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
49
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Adge
|
5.1K |
2.5M |
3 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
5.1K
|
2.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Adge
|
5.1K |
2.5M |
11 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
5.1K
|
2.5M
|
11
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Adge
|
137K |
52M |
8 |
18/03/23 |
18/03/23 |
ASX - By Stock
|
137K
|
52M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Adge
|
618 |
235K |
7 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
618
|
235K
|
7
|
|
ASX - By Stock
|
AVZ |
Re:
Deeland Offer
|
|
Adge
|
100 |
68K |
3 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
100
|
68K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Adge
|
576 |
203K |
5 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
203K
|
5
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Adge
|
81K |
48M |
11 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
81K
|
48M
|
11
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Adge
|
137K |
52M |
3 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
137K
|
52M
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on First In Human DurAVR THV Study
|
|
Adge
|
41 |
14K |
1 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
41
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Completion of Second First-In-Human Study
|
|
Adge
|
20 |
9.6K |
1 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
20
|
9.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Completion of Second First-In-Human Study
|
|
Adge
|
20 |
9.6K |
5 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
20
|
9.6K
|
5
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Adge
|
81K |
48M |
57 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
81K
|
48M
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Adge
|
17K |
6.6M |
8 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
17K
|
6.6M
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: EXPANSION OF FIRST IN HUMAN TRIAL
|
|
Adge
|
4 |
2.8K |
12 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
4
|
2.8K
|
12
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Adge
|
81K |
48M |
9 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
81K
|
48M
|
9
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Adge
|
81K |
48M |
8 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
81K
|
48M
|
8
|
|
ASX - By Stock
|
IFM |
Re:
Ann: TA Consortium notice of initial substantial holder
|
|
Adge
|
2 |
1.0K |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
2
|
1.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Adge
|
138 |
52K |
12 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
138
|
52K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions to be submitted to the CEO
|
|
Adge
|
74 |
23K |
6 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
74
|
23K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Adge
|
10K |
4.7M |
1 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
10K
|
4.7M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Adge
|
10K |
4.7M |
7 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Adge
|
10K |
4.7M |
4 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
Adge
|
57 |
15K |
3 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Quarterly Update / Appendix 4C
|
|
Adge
|
241 |
71K |
0 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
241
|
71K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: TGA Registration Update
|
|
Adge
|
2.4K |
725K |
13 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
2.4K
|
725K
|
13
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Alofisel® Japan Royalties
|
|
Adge
|
3 |
2.0K |
11 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
3
|
2.0K
|
11
|
|